Arcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 Results Seeking Alpha, 23 Mar 2023 Follow Summary Arcus’s pipeline includes several promising candidates, including domvanalimab, an Fc-silent anti-TIGIT antibody…